Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ECC:CDNX - EPS Capital Corporation -- Ignore unavailable to you. Want to Upgrade?

To: VIP Condo who wrote (6)	3/27/2001 2:34:16 PM
From: Nick Morvay	Read Replies (1) \| Respond to of 10

Kaiser says EPS Capital does it according to CDNX book EPS Capital Corp ECC Shares issued 2,900,000 Mar 26 close $7.05 Tue 27 Mar 2001 In the News John Kaiser, writing in a March 25 Express, says EPS Capital, then $6.60, is a good example of the shell-creating model as envisioned by the Canadian Venture Exchange. EPS Capital went public on March 21 with an initial public offering of 1.3 million shares at 20 cents. EPS stock traded as high as $7 on opening day, creating paper wealth of nearly $400-million through about $1.3 million worth of trading by investors "who can hardly be described as independent." Mr. Kaiser says EPS plans to acquire a private company called Rycor which is related to EPS insiders; Rycor has obtained the rights to a potential multiple sclerosis cure. Rycor has privately raised $19-million at an average price of $1.10 with unnamed parties. Then came a $17-million investment at $2.50 in a strategy called value benchmarking. He contends the Rycor "crowd" has benchmarked a $400-million market value for the project, which makes Yorkton Securities' $8.25-million private placement at $2.50 an easy sell. Mr. Kaiser says the CDNX's approach is a "one-way street philosophy where the elite comes to the trough early and the public is invited as the feast." (c) Copyright 2001 Canjex Publishing Ltd. stockwatch.com